Skip to main content
GutCited

Berberine para Small Intestinal Bacterial Overgrowth (SIBO)

C

Herbal antimicrobial protocol including berberine showed comparable efficacy to rifaximin for SIBO in retrospective study. Prospective RCT data limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dsibo'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
Conclusión

            
            
Herbal antimicrobial protocol including berberine showed comparable efficacy to rifaximin for SIBO in retrospective study. Prospective RCT data limited.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Meta-Analysis
                
                
                n=1552
                
                
                
            

            
                Comparative efficacy of diverse therapeutic regimens for small intestinal bacterial overgrowth: a systematic network meta-analysis.
            
            

                
                Dose: None
                
                
                vs: Multiple comparators (network meta-analysis)
                
                
                Outcome: SIBO eradication rate
                
                
                Efecto: Berberine highest SUCRA
                
                
                None
                
            

            
            
Población: Adults with SIBO from 30 RCTs

            
        

        
        

            

                
                    Randomized Controlled Trial
                
                
                
                2 weeks
                
                
                Open-label
                
            

            
                Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, …
            
            

                
                Dose: 400 mg d
                
                
                vs: control
                
                
                Outcome: a negative breath test
                
                
                Efecto: None
                
                
                None
                
            

            
            
Población: Long-term abdominal discomfort and avoiding excessive examination

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
2

        
Estudios

    

    

        
180

        
Participantes

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
Calificación

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Comparative efficacy of diverse therapeutic regimens for small intestinal bacterial overgrowth: a systematic network meta-analysis.
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        Therapeutic advances in …
                        2025
                        
                    

                

                
                

                    

                        
                            Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO …
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        Frontiers in pharmacology
                        2023
                        
                        8 citas
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Dosificaciones de uso común

                

                    
                    

                        
general:

                        
500-1,500 mg/day in divided doses

                    

                    
                    

                        
siboprotocol:

                        
500 mg two to three times daily for 4 weeks (as part of herbal antimicrobial protocol)

                    

                    
                    

                        
giantimicrobial:

                        
500 mg twice daily

                    

                    
                

                
                

                    Límite superior: Generally well-tolerated up to 1,500 mg/day in divided doses
                

                
            

            

            
            

                
Dosificaciones estudiadas en la investigación

                

                    

                        
                            

                                Dosificación
                                Duración
                                Efecto
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                1552
                            

                            
                            

                                400 mg d
                                2 weeks
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                Mejor momento para tomar: With meals; divide doses throughout the day (do not take full daily dose at once)
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Efectos secundarios reportados

                    
    
                        
                        
  • 
                            ⚠
                            GI side effects (diarrhea, constipation, flatulence, abdominal pain) — most common
                        
    • 
                        
                        
  • 
                            ⚠
                            May cause uterine contractions (contraindicated in pregnancy)
                        
    • 
                        
                        
  • 
                            ⚠
                            Headache
                        
    • 
                        
                        
  • 
                            ⚠
                            Skin rash (rare)
                        
    • 
                        
                    

                

                

                
                

                    
Interacciones conocidas

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (berberine significantly lowers blood sugar; risk of hypoglycemia)
                        
    • 
                        
                        
  • 
                            ●
                            Cyclosporine (berberine inhibits CYP3A4, increasing cyclosporine levels)
                        
    • 
                        
                        
  • 
                            ●
                            Anticoagulants (may have additive blood-thinning effects)
                        
    • 
                        
                        
  • 
                            ●
                            Metformin (additive glucose-lowering effect; monitor closely)
                        
    • 
                        
                        
  • 
                            ●
                            Macrolide antibiotics (berberine inhibits CYP3A4)
                        
    • 
                        
                    

                

                

                
                

                    

                        Ingesta máxima tolerable: Generally well-tolerated up to 1,500 mg/day in divided doses
                    

                

                
            

            

                Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Berberine help with Small Intestinal Bacterial Overgrowth (SIBO)?
            
        
        

            Based on 2 studies with 180 participants, there is limited but promising evidence that Berberine may support Small Intestinal Bacterial Overgrowth (SIBO) management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much Berberine should I take for Small Intestinal Bacterial Overgrowth (SIBO)?
            
        
        

            Studies have used various dosages. A commonly studied range is 500-1,500 mg/day in divided doses. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Berberine?
            
        
        

            Reported side effects may include GI side effects (diarrhea, constipation, flatulence, abdominal pain) — most common, May cause uterine contractions (contraindicated in pregnancy), Headache, Skin rash (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Berberine and Small Intestinal Bacterial Overgrowth (SIBO)?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 180 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                

                    
Otros ingredientes para Small Intestinal Bacterial Overgrowth (SIBO)

                    

                        
                        
                            Partially Hydrolyzed Guar Gum (PHGG)
                            C

                        
                        
                    

                

                

                
                

                    
Berberine para otras condiciones

                    

                        
                        
                            Acute Diarrhea
                            C

                        
                        
                        
                            Gut Dysbiosis
                            D

                        
                        
                    

                

                
            

        

        

    


    
    












    

        Aviso legal FDA:
        Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.